Chronicus myeloid leukaemia kezelése interferon-alpha-val.

Translated title of the contribution: Treatment of chronic myeloid leukemia with interferon-alpha

A. Szomor, L. Molnár, A. Nagy, M. Dávid, H. Alizadeh, M. Kecskés, T. Vidra, L. Kereskai, L. Pajor, H. Losonczy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The authors have treated 38 patients with chronic phase chronic myeloid leukemia in their single center in the last five years. Conventional chemotherapy provided about 40-50% hematological response, interferon-alpha seems to be more effective, complete hematological remission occurred in 65%. Interphase cytogenetics and fluorescein in situ hybridisation technique was used to measure the cytogenetic response. They observed complete cytogenetic remission in two cases (8%), major response in 11 (39%), minor response in 4 (15%) and minimal response in 4 cases (15%). Interferon-alpha is an effective, well-tolerated medicine in the treatment of chronic myeloid leukemia.

Translated title of the contributionTreatment of chronic myeloid leukemia with interferon-alpha
Original languageHungarian
Pages (from-to)2601-2604
Number of pages4
JournalOrvosi hetilap
Volume141
Issue number48
Publication statusPublished - Nov 26 2000

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Treatment of chronic myeloid leukemia with interferon-alpha'. Together they form a unique fingerprint.

  • Cite this

    Szomor, A., Molnár, L., Nagy, A., Dávid, M., Alizadeh, H., Kecskés, M., Vidra, T., Kereskai, L., Pajor, L., & Losonczy, H. (2000). Chronicus myeloid leukaemia kezelése interferon-alpha-val. Orvosi hetilap, 141(48), 2601-2604.